A citation-based method for searching scientific literature

Diane H Song, Lisa Getty-Kaushik, Eva Tseng, Jonathan Simon, Barbara E Corkey, M Michael Wolfe. Gastroenterology 2007
Times Cited: 92







List of co-cited articles
1119 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Inhibition of gastric inhibitory polypeptide signaling prevents obesity.
Kazumasa Miyawaki, Yuichiro Yamada, Nobuhiro Ban, Yu Ihara, Katsushi Tsukiyama, Heying Zhou, Shimpei Fujimoto, Akira Oku, Kinsuke Tsuda, Shinya Toyokuni,[...]. Nat Med 2002
633
60


Biology of incretins: GLP-1 and GIP.
Laurie L Baggio, Daniel J Drucker. Gastroenterology 2007
32


GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet.
Paula L McClean, Nigel Irwin, Roslyn S Cassidy, Jens J Holst, Victor A Gault, Peter R Flatt. Am J Physiol Endocrinol Metab 2007
185
27


Functional GIP receptors are present on adipocytes.
R G Yip, M O Boylan, T J Kieffer, M M Wolfe. Endocrinology 1998
175
25

Glucose-dependent insulinotropic polypeptide modulates adipocyte lipolysis and reesterification.
Lisa Getty-Kaushik, Diane H Song, Michael O Boylan, Barbara E Corkey, M Michael Wolfe. Obesity (Silver Spring) 2006
84
27

Stimulation of insulin secretion by gastric inhibitory polypeptide in man.
J Dupre, S A Ross, D Watson, J C Brown. J Clin Endocrinol Metab 1973
729
22

Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice.
K Miyawaki, Y Yamada, H Yano, H Niwa, N Ban, Y Ihara, A Kubota, S Fujimoto, M Kajikawa, A Kuroe,[...]. Proc Natl Acad Sci U S A 1999
356
22


Glucose-dependent insulinotropic polypeptide stimulation of lipolysis in differentiated 3T3-L1 cells: wortmannin-sensitive inhibition by insulin.
C H McIntosh, I Bremsak, F C Lynn, R Gill, S A Hinke, R Gelling, C Nian, G McKnight, S Jaspers, R A Pederson. Endocrinology 1999
50
38



Extrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditure.
Tanya Hansotia, Adriano Maida, Grace Flock, Yuichiro Yamada, Katsushi Tsukiyama, Yutaka Seino, Daniel J Drucker. J Clin Invest 2007
209
18







Effect of gastric inhibitory polypeptide on plasma levels of chylomicron triglycerides in dogs.
T Wasada, K McCorkle, V Harris, K Kawai, B Howard, R H Unger. J Clin Invest 1981
131
15


GIP biology and fat metabolism.
R G Yip, M M Wolfe. Life Sci 2000
212
14

The biology of incretin hormones.
Daniel J Drucker. Cell Metab 2006
14


Glucose-dependent insulinotropic polypeptide (Gastric Inhibitory Polypeptide; GIP).
Christopher H S McIntosh, Scott Widenmaier, Su-Jin Kim. Vitam Horm 2009
114
14

GIP receptor mRNA expression in different fat tissue depots in postmenopausal non-diabetic women.
Natalia Rudovich, Simone Kaiser, Stefan Engeli, Martin Osterhoff, Ozlem Gögebakan, Matthias Bluher, Andreas F H Pfeiffer. Regul Pept 2007
36
33

Vaccination against GIP for the treatment of obesity.
Alma Fulurija, Thomas A Lutz, Katja Sladko, Melania Osto, Peter Y Wielinga, Martin F Bachmann, Philippe Saudan. PLoS One 2008
72
16

Glucose-dependent insulinotropic polypeptide may enhance fatty acid re-esterification in subcutaneous abdominal adipose tissue in lean humans.
Meena Asmar, Lene Simonsen, Sten Madsbad, Bente Stallknecht, Jens Juul Holst, Jens Bülow. Diabetes 2010
93
13

GIP-overexpressing mice demonstrate reduced diet-induced obesity and steatosis, and improved glucose homeostasis.
Su-Jin Kim, Cuilan Nian, Subashini Karunakaran, Susanne M Clee, Carlos M Isales, Christopher H S McIntosh. PLoS One 2012
96
13

Glucose-dependent insulinotropic polypeptide is a growth factor for beta (INS-1) cells by pleiotropic signaling.
A Trümper, K Trümper, H Trusheim, R Arnold, B Göke, D Hörsch. Mol Endocrinol 2001
201
11


Glucagon-like peptide-1 7-36: a physiological incretin in man.
B Kreymann, G Williams, M A Ghatei, S R Bloom. Lancet 1987
11


Inhibition of GIP signaling modulates adiponectin levels under high-fat diet in mice.
Rei Naitoh, Kazumasa Miyawaki, Norio Harada, Wataru Mizunoya, Kentaro Toyoda, Tohru Fushiki, Yuichiro Yamada, Yutaka Seino, Nobuya Inagaki. Biochem Biophys Res Commun 2008
48
22


Glucose-dependent insulinotropic polypeptide: a bifunctional glucose-dependent regulator of glucagon and insulin secretion in humans.
Mikkel Christensen, Louise Vedtofte, Jens J Holst, Tina Vilsbøll, Filip K Knop. Diabetes 2011
200
11

Chronic reduction of GIP secretion alleviates obesity and insulin resistance under high-fat diet conditions.
Daniela Nasteska, Norio Harada, Kazuyo Suzuki, Shunsuke Yamane, Akihiro Hamasaki, Erina Joo, Kanako Iwasaki, Kimitaka Shibue, Takanari Harada, Nobuya Inagaki. Diabetes 2014
118
11


Effects of glucose-dependent insulinotropic peptide on osteoclast function.
Qing Zhong, Takashi Itokawa, Supriya Sridhar, Ke-Hong Ding, Ding Xie, Baolin Kang, Wendy B Bollag, Roni J Bollag, Mark Hamrick, Karl Insogna,[...]. Am J Physiol Endocrinol Metab 2007
135
10

Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120.
Akira Hirasawa, Keiko Tsumaya, Takeo Awaji, Susumu Katsuma, Tetsuya Adachi, Masateru Yamada, Yukihiko Sugimoto, Shunichi Miyazaki, Gozoh Tsujimoto. Nat Med 2005
10

Glucose-dependent insulinotropic polypeptide promotes beta-(INS-1) cell survival via cyclic adenosine monophosphate-mediated caspase-3 inhibition and regulation of p38 mitogen-activated protein kinase.
Jan A Ehses, Vanbric R Casilla, Tim Doty, J Andrew Pospisilik, Kyle D Winter, Hans-Ulrich Demuth, Raymond A Pederson, Christopher H S McIntosh. Endocrinology 2003
129
10

Chemical ablation of gastric inhibitory polypeptide receptor action by daily (Pro3)GIP administration improves glucose tolerance and ameliorates insulin resistance and abnormalities of islet structure in obesity-related diabetes.
Victor A Gault, Nigel Irwin, Brian D Green, Jane T McCluskey, Brett Greer, Clifford J Bailey, Patrick Harriott, Finbarr P M O'harte, Peter R Flatt. Diabetes 2005
124
10


Gastric inhibitory polypeptide (GIP) dose-dependently stimulates glucagon secretion in healthy human subjects at euglycaemia.
J J Meier, B Gallwitz, N Siepmann, J J Holst, C F Deacon, W E Schmidt, M A Nauck. Diabetologia 2003
222
10

Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance.
Kirsten Vollmer, Jens J Holst, Birgit Baller, Mark Ellrichmann, Michael A Nauck, Wolfgang E Schmidt, Juris J Meier. Diabetes 2008
248
10


Glucose-dependent insulinotropic peptide-overexpressing transgenic mice have increased bone mass.
Ding Xie, Qing Zhong, Ke-Hong Ding, Hua Cheng, Sandra Williams, Daniel Correa, Wendy B Bollag, Roni J Bollag, Karl Insogna, Nancy Troiano,[...]. Bone 2007
104
10



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.